首页 News 正文

Smeaglutide tablet for type 2 diabetes was approved for marketing in China

海角七号
252 0 0

Reporters learned from the State Food and Drug Administration on January 26 that Novo Nordisk Megglutide Tablets have been approved by the State Food and Drug Administration (NMPA) for marketing to treat type 2 diabetes. This is the first domestically approved oral GLP-1 (glucagon like peptide-1) receptor agonist.
CandyLake.com 系信息发布平台,仅提供信息存储空间服务。
声明:该文观点仅代表作者本人,本文不代表CandyLake.com立场,且不构成建议,请谨慎对待。
您需要登录后才可以回帖 登录 | 立即注册

本版积分规则

海角七号 注册会员
  • 粉丝

    0

  • 关注

    1

  • 主题

    29